Global Search

Search articles, concepts, and chapters

Scott Ingrid U

20 articles in GJC

20 articles in GJC

1.

Adaptive optics cone arrangement in hydroxychloroquine users without signs of retinal toxicity based on current screening guidelines: a case-control study.

Braga João Pedro Romero, Lucena Moisés Moura, Rodrigues Murilo Wendeborn, Zupelli Arthur, Scott Ingrid U, Messias André et al.

Graefes Arch Clin Exp OphthalmolFeb 20252 citationsCase-Control Study

Adaptive optics detected reduced cone density and increased spacing in hydroxychloroquine users without standard toxicity signs, suggesting it could be an earlier screening tool.

3.

Safety and efficacy of topical vs intracanalicular corticosteroids for the prevention of postoperative inflammation after cataract surgery.

Lu Amy Q, Rizk Monica, O'Rourke Tara, Goodling Kristin, Lehman Erik, Scott Ingrid U et al.

J Cataract Refract SurgMay 202212 citationsCase Series

This study compared topical prednisolone to intracanalicular dexamethasone for post-cataract inflammation. Both methods showed similar rates of breakthrough inflammation and IOP elevation, suggesting the insert is a comparable alternative for prophylaxis.

4.

Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.

Aref Ahmad A, Scott Ingrid U, VanVeldhuisen Paul C, King Jacquie, Ip Michael S, Blodi Barbara A et al.

JAMA OphthalmolDec 20218 citationsRandomized Controlled Trial

This study found anti-VEGF injections for retinal vein occlusion cause low rates of significant IOP elevation or glaucoma surgery, emphasizing the need for long-term IOP monitoring.

5.

Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.

Aref Ahmad A, Scott Ingrid U, Oden Neal L, Ip Michael S, Blodi Barbara A, VanVeldhuisen Paul C

JAMA OphthalmolSep 20150 citationsRandomized Controlled Trial

This study found 4mg intravitreal triamcinolone significantly increases IOP risk, especially in younger patients with higher baseline IOP, often occurring weeks after injection, necessitating careful monitoring.

9.

SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.

Chan Clement K, Ip Michael S, Vanveldhuisen Paul C, Oden Neal L, Scott Ingrid U, Tolentino Michael J et al.

OphthalmologyJul 201159 citationsRandomized Controlled Trial

The SCORE study found triamcinolone didn't reduce neovascular events in RVO. Neovascularization risk significantly increased with greater retinal nonperfusion, especially in BRVO, highlighting nonperfusion as a key risk factor.

10.

Intravitreal injection versus subtenon infusion of triamcinolone acetonide during cataract surgery in patients with refractory diabetic macular edema.

Takata Clécio, Messias Andre, Folgosa Marco S, Lucena Levy R, Lucena Daniel R, Scott Ingrid U et al.

RetinaApr 201025 citationsRandomized Controlled Trial

This study found intravitreal triamcinolone during cataract surgery was more effective than subtenon infusion for refractory diabetic macular edema, improving vision and reducing macular thickness, suggesting a superior approach.

11.

One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion.

Gregori Ninel Z, Rosenfeld Philip J, Puliafito Carmen A, Flynn Harry W, Lee Ji Eun, Mavrofrides Elias C et al.

RetinaOct 200666 citationsObservational Study

This study found IVTA for CRVO macular edema offered limited, transient visual improvement in some patients, with many eyes stable but not improved at one year, and significant IOP elevation risk.

All 20 articles loaded